Manchester Financial’s Stemline Therapeutics, Inc. STML Stock Holding History

Manchester Financial’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	–	–	587
2020 Q1	$0	Hold	100	–	–	﹤0.01%	660
2019 Q4	$1K	Buy	+100	New	+$993	﹤0.01%	552
2019 Q3	–	Sell	-100	Closed	-$2K	–	498
2019 Q2	$2K	Buy	+100	New	+$1.45K	﹤0.01%	455

Manchester Financial's STML Position: Q2 2020 in Review

Manchester Financial sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 100 shares.

Manchester Financial first reported a position in STML in Q2 2019 and held it in 3 quarters. The position peaked at $2K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Manchester Financial reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Manchester Financial sold 100 Stemline Therapeutics, Inc. shares in Q2 2020.
Manchester Financial first reported a position in Stemline Therapeutics, Inc. in Q2 2019 and held it in 3 quarters.
Manchester Financial's Stemline Therapeutics, Inc. position peaked at $2K in Q2 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Manchester Financial's 13F filing for Q2 2020, filed 13 Jul 2020.